Marimed (MRMD) Total Current Liabilities (2011 - 2026)

Marimed (MRMD) has 16 years of Total Current Liabilities data on file, last reported at $63.8 million in Q1 2026.

• On a quarterly basis, Total Current Liabilities rose 15.28% year-over-year to $63.8 million in Q1 2026; TTM through Mar 2026 was $63.8 million, a 15.28% increase from a year earlier, with the FY2025 full-year figure at $59.1 million, up 18.12% from the prior year.
• Total Current Liabilities for Q1 2026 stood at $63.8 million, up from $59.1 million in the prior quarter.
• Over the last five years, Total Current Liabilities for MRMD reached as high as $63.8 million in Q1 2026 and fell as low as $24.5 million in Q1 2023.
• Historically, Total Current Liabilities has averaged $40.6 million across 5 years, with a median of $35.5 million in 2024.
• Across the five-year window, Total Current Liabilities jumped 134.89% in 2022 and dropped 28.3% in 2023, its largest moves.
• Year by year, Total Current Liabilities stood at $26.5 million in 2022, then increased by 16.5% to $30.9 million in 2023, then soared by 62.03% to $50.0 million in 2024, then climbed by 18.12% to $59.1 million in 2025, then climbed by 7.94% to $63.8 million in 2026.
• Per Business Quant data, the three most recent Total Current Liabilities figures were $63.8 million in Q1 2026, $59.1 million in Q4 2025, and $56.6 million in Q3 2025.